191 related articles for article (PubMed ID: 18204866)
1. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Pediatr Nephrol; 2008 Apr; 23(4):611-8. PubMed ID: 18204866
[TBL] [Abstract][Full Text] [Related]
2. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide toxicity in cultured proximal renal tubule cells.
Springate J; Taub M
Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
6. Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.
Schwerdt G; Kirchhoff A; Freudinger R; Wollny B; Benesic A; Gekle M
Pediatr Nephrol; 2007 Jun; 22(6):798-803. PubMed ID: 17273862
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide and mesna: effects on the Na/H exchanger activity in renal epithelial cells in culture (LLC-PK1).
Mohrmann M; Küpper N; Schönfield B; Brandis M
Ren Physiol Biochem; 1995; 18(3):118-27. PubMed ID: 7542792
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Arch Toxicol; 2008 Sep; 82(9):607-14. PubMed ID: 18214444
[TBL] [Abstract][Full Text] [Related]
9. Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity.
Benesic A; Schwerdt G; Mildenberger S; Freudinger R; Gordjani N; Gekle M
Kidney Int; 2005 Nov; 68(5):2029-41. PubMed ID: 16221203
[TBL] [Abstract][Full Text] [Related]
10. Targets of chloroacetaldehyde-induced nephrotoxicity.
Knouzy B; Dubourg L; Baverel G; Michoudet C
Toxicol In Vitro; 2010 Feb; 24(1):99-107. PubMed ID: 19733226
[TBL] [Abstract][Full Text] [Related]
11. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide.
Dubourg L; Michoudet C; Cochat P; Baverel G
J Am Soc Nephrol; 2001 Aug; 12(8):1615-1623. PubMed ID: 11461933
[TBL] [Abstract][Full Text] [Related]
12. Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats.
Kanat O; Kurt E; Yalcinkaya U; Evrensel T; Manavoglu O
Indian J Cancer; 2006; 43(1):12-5. PubMed ID: 16763356
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of chloroacetaldehyde is similar in adult and pediatric kidney tubules.
Dubourg L; Tanière P; Cochat P; Baverel G; Michoudet C
Pediatr Nephrol; 2002 Feb; 17(2):97-103. PubMed ID: 11875671
[TBL] [Abstract][Full Text] [Related]
14. Atractyloside nephrotoxicity: in vitro studies with suspensions of rat renal fragments and precision-cut cortical slices.
Obatomi DK; Bach PH
In Vitr Mol Toxicol; 2000; 13(1):25-36. PubMed ID: 10900405
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna.
Meier T; Allenbacher A; Mueller E; Multhoff G; Botzler C; Wiesnet M; Issels R
Anticancer Drugs; 1994 Aug; 5(4):403-9. PubMed ID: 7949243
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
[TBL] [Abstract][Full Text] [Related]
17. Free reactive oxygen species and nephrotoxicity of contrast agents.
Haeussler U; Riedel M; Keller F
Kidney Blood Press Res; 2004; 27(3):167-71. PubMed ID: 15256812
[TBL] [Abstract][Full Text] [Related]
18. BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
Boven E; Verschraagen M; Hulscher TM; Erkelens CA; Hausheer FH; Pinedo HM; van der Vijgh WJ
Eur J Cancer; 2002 May; 38(8):1148-56. PubMed ID: 12008205
[TBL] [Abstract][Full Text] [Related]
19. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.
Hensley ML; Schuchter LM; Lindley C; Meropol NJ; Cohen GI; Broder G; Gradishar WJ; Green DM; Langdon RJ; Mitchell RB; Negrin R; Szatrowski TP; Thigpen JT; Von Hoff D; Wasserman TH; Winer EP; Pfister DG
J Clin Oncol; 1999 Oct; 17(10):3333-55. PubMed ID: 10506637
[TBL] [Abstract][Full Text] [Related]
20. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
Batista CK; Mota JM; Souza ML; Leitão BT; Souza MH; Brito GA; Cunha FQ; Ribeiro RA
Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
